Wed.Jan 08, 2025

article thumbnail

Five Key Skills for Pharmacy Residents

IDStewardship

In this article, five key skills for pharmacy residents are identified and discussed. Authored by:Asma Alamri, Pharm.D. &Huda Almalki, Pharm.D. Post-Graduate Year-1Pharmacy Residents, Taif Health Cluster, Saudi Arabia Mentored by: Sameer Alzaidi, Pharm.D., BCPS, BCIDP, AAHIVP System-Wide Post-Graduate Year-1Pharmacy Residency Program Director, Taif Health Cluster, Saudi Arabia UNDER CONSTRUCTION Article Posted January 2024 According to the American College of Clinical Pharmacy (ACCP a reside

article thumbnail

Challenges for Pharmacies in 2025: What to Expect and How to Prepare

Drug Topics

Pharmacy professionals are used to overcoming obstacles in this competitive, dynamic field. But the coming year will bring challenges affecting patient care, the industry workforce and their business. Pharmacies must be ready to do more than weather the storm; they need deliberate strategy and sophisticated tools to thrive amidst these obstacles. This white paper will discuss the issues and solutions that should be at the top of every pharmacy professionals mind as they start the new year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Investors call on UnitedHealth to disclose human and economic costs of policies that limit care

STAT

Seven UnitedHealth Group shareholders are calling on the health care conglomerate to produce a report on how often its policies lead to denied or delayed care, and the effects on patients and the economy.  The proposal , which could go up for a vote by UnitedHealth’s investors at the company’s annual meeting later this year, comes as the company is under tremendous public scrutiny for tactics such as prior authorization and care denials.

Insurance 145
article thumbnail

Pharmacists Must Be Aware of Polypharmacy Risk in Patients With Long COVID

Drug Topics

Henry Ukachukwu Michael, PhD, discusses the importance of optimizing medication utilization in patients with long COVID.

371
371
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

3 trial readouts that could shake up the obesity market this year

PharmaVoice

A wave of new weight loss treatments is on the way, and drugmakers are scrambling for a foot in the door.

276
276
article thumbnail

FDA Requires Abrysvo, Arexvy RSV Vaccine Labels to Include Guillain-Barré Warning

Drug Topics

Patients who receive either Pfizer or GSKs respiratory syncytial virus vaccine may be at increased risk of Guillain-Barr syndrome.

Vaccines 307

More Trending

article thumbnail

Long-Acting GLP-1 Shows Positive Results in Phase 2 Study

Drug Topics

MET-097i from Metsera demonstrated substantial reductions in mean body weight in patients with obesity or overweight who did not have type 2 diabetes.

281
281
article thumbnail

Avoiding Medicare Penalties: Navigating Challenges with PharmD Live Solutions

PharmD Live

Medicares increasing focus on quality metrics in 2025 presents critical challenges for healthcare providers. With penalties for non-compliance reaching as high as 9% of reimbursements, practices risk significant financial and operational strain. By leveraging solutions like PharmD Live, providers can navigate these challenges effectively, safeguard revenue and improve patient care.

article thumbnail

McKesson Amplify Initiative Secures Funding for State Pharmacy Associations

Drug Topics

Six months after the announcement of McKesson Amplify in June, the initiative has secured funding across all 50 states in the US.

247
247
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Healthcare tech company H1 picked up Ribbon Health, a provider data management software company to broaden its reach into the health plan, provider system and digital health sectors.

136
136
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

ACIP Publishes Final Pneumococcal Vaccine Recommendations

Drug Topics

These recommendations were voted on at the October 2024 Advisory Committee on Immunization Practices meeting.

Vaccines 190
article thumbnail

US Surgeon General Reports Alcohol Use Linked to Increased Cancer Risk

Pharmacy Times

The advisory emphasizes the need for a comprehensive approach to reducing alcohol-related cancer by combining prevention, education, and treatment to improve public health outcomes.

130
130
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for alternative ways to administer anti-obesity drugs. | Found is offering a cheaper, more personalized GLP-1 medication for individuals hesitant to administer injections.

126
126
article thumbnail

Report Links GLP-1 Medication to Decrease in Consumer-Packaged Goods, Food, and Beverages

Pharmacy Times

The data from the report show how nutritional choices compliment the use of glucagon-like peptide-1 receptor agonists and how health care providers can educate patients further.

Packaging 129
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

More than 23 million people have selected coverage on the Affordable Care Act's exchange as part of open enrollment, according to data from the Centers for Medicare & Medicaid Services.

126
126
article thumbnail

Non-Invasive Nasal Swab Can Diagnose Specific Asthma Endotype in Young Patients

Pharmacy Times

The investigators note that the test can allow health care professionals to more accurately prescribe medication or treatments.

122
122
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Blue Shield of California is restructuring its corporate operations, including a change at the top that brings in its first-ever female CEO. | Blue Shield of California is restructuring its corporate operations, including a change at the top that brings in its first-ever female CEO.

125
125
article thumbnail

Reuters Pharma USA 2025

Pharma Marketing Network

Reuters Pharma USA 2025 will unite senior pharma leaders across commercial, marketing, medical affairs, patient engagement, market access, real world evidence and data for two days of learnings in Philadelphia. The 2025 agenda is streamed by priority spotlighting use cases and tangible learnings across the key topic areas of customer engagement, tools and technology, value demonstration, and future proofing strategies.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

A new survey indicates health plan members trust AI capabilities but feel their plan could utilize the technology more effectively to improve the experience.

110
110
article thumbnail

2025 BCACP Exam – How To Prepare For Success

Med Ed 101

The (Ambulatory Care Pharmacist) BCACP exam changed slightly in 2024 and overall, the 2025 BCACP exam is going to remain the same…UNTIL October 1st, 2025. How does this affect you if you want to become board-certified in 2025? Watch the video below! Pass rates are historically better for the BCACP exam compared to the BCPS […] The post 2025 BCACP Exam – How To Prepare For Success appeared first on Med Ed 101.

105
105
article thumbnail

J&J says Rybrevant combo has survival edge over Tagrisso

pharmaphorum

Rybrevant plus Lazcluze extended median OS by more than a year compared to Tagrisso in the MARIPOSA trial in treatment-naive, EGFR-mutated NSCLC

105
105
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Employee healthcare navigation company Transcarent plans to acquire health benefits platform Accolade in a deal valued at $621 million, the company announced Wednesday.

97
article thumbnail

11 blockbuster drugs to look out for in 2025

pharmaphorum

Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.

105
105
article thumbnail

Reuters Pharma EU 2025

Pharma Marketing Network

Reuters Pharma in Barcelona is the global collaborative network for leading pharma innovators, where 1,200+ like-minded leaders and trusted partners will connect, learn and make long-lasting impacts. For 23 years, Reuters Pharma in Barcelona has been the industry’s collaborative home. Our 2025 agenda has been designed from the ground up alongside your colleagues, competitors and industry experts to give you practical action, with a reimagined mix of fresh perspectives, interactive sessions

52
article thumbnail

Novo Nordisk swells alliance with AI firm Valo Health

pharmaphorum

Novo Nordisk almost doubles the scale of its R&D alliance with AI specialist Valo Health, which now spans 20 programmes and a value of up to $4.6bn.

98
article thumbnail

Advancing Anaphylaxis Treatment With Needle-Free Epinephrine Delivery

Pharmacy Times

Intranasal epinephrine spray offers a needle-free option for anaphylaxis treatment.

93
article thumbnail

Galapagos unveils plan to split, hiving off its drugs unit

pharmaphorum

Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its drug development and cell therapy operations.

98
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

New startup Qualified Health aims to work with health systems to tackle foundational issues around governance, security and trust to build a generative AI infrastructure for healthcare.

86
article thumbnail

The biopharma outlook for 2025: Opportunities and challenges

pharmaphorum

With the Federal Reserve poised to implement interest rate cuts (albeit fewer than earlier forecasts assumed) and FTC leadership turnover anticipated, there may be broader shifts in how capital is both sourced and used in the biopharma industry.

97
article thumbnail

Systemic Immune-Inflammation Index Associated With Increased Risk of Depressive Symptoms

Pharmacy Times

Depression and cardiovascular disease are often linked, with research showing inflammation is common for the 2 disease states.

article thumbnail

Aviceda raises $207.5m for eye drug, and other financings

pharmaphorum

Our round-up of recent biotech financings includes a big round for Aviceda, with Orbis, Alebund, XyloCor, and PrimeGene also raising additional cash.

96
article thumbnail

Children With Autism Are More Likely to Be Diagnosed with Leukemia, Study Finds

Pharmacy Times

This association was also observed in siblings of children with autism spectrum disorder.

73
article thumbnail

Access to cells for CGT is closer than you think

pharmaphorum

Access to cells for CGT is closer than you think Nicole.

94